Atlas Trials

HBPL Study of the Impact of the NK1 Antagonist Aprepitant

Clinical trial NCT01176591 · COMPLETED

Trial details

NCT number
NCT01176591
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cocaine DependenceAlcohol Dependence
Start date
2010-09-01
Primary completion
2013-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.